Capabilities


 

PHASE 0 & I STUDY EXPERIENCE INCLUDE:

  • First-in-Human (FIM)Single Ascending Dose (SAD)
  • Multiple Ascending Dose (MAD)
  • Adaptive/Accelerated Protocols
  • PK, PD, BD
  • Food Effect
  • Drug/Drug Interaction
  • Age & Gender
  • Special Populations with specific diseases(CHF, CRF, Malignancies etc.)
  • Bioavailability/Bioequivalence (For Biosimilar or Generic Version)

PHASE I/II STUDIES: NHCR will help the sponsor to combine Phase I and Phase II for:

  • Efficacy (response to new treatment)
  • Toxicity (safety, dosage levels)
Location
New Hope Clinical Research
3101 Latrobe Dr
Charlotte, NC 28211
Phone: 980-228-9547
Fax: 980-226-5843
Office Hours

Get in touch

980-228-9547